Literature DB >> 10811317

Variant forms of cholestatic diseases involving small bile ducts in adults.

W R Kim1, J Ludwig, K D Lindor.   

Abstract

OBJECTIVE: Cholestasis may result from diverse etiologies. We review chronic cholestatic disorders involving small intrahepatic bile ducts in the adult ambulatory care setting. Specifically, we discuss variant forms of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) as well as other conditions that may present diagnostic and therapeutic difficulties.
METHODS: We conducted a MEDLINE search of the literature (1981-1997) and reviewed the experiences at the Mayo Clinic. All articles were selected that discussed antimitochondrial antibody (AMA)-negative PBC, small-duct PSC (formerly pericholangitis), and idiopathic adulthood ductopenia.
RESULTS: The most common chronic cholestatic liver diseases affecting adults are PBC and PSC. Patients without the hallmarks of either syndrome are diagnosed according to their clinical and histological characteristics. Autoimmune cholangitis is diagnosed if clinical and histological features are compatible with PBC but autoantibodies other than AMA are present. Isolated small duct PSC is diagnosed if patients have inflammatory bowel disease, biopsy features compatible with PSC, but a normal cholangiogram. If ductopenia (absence of interlobular bile ducts in small portal tracts) is found histologically in the absence of PSC, inflammatory bowel disease, and other specific cholestatic syndromes such as drug reaction or sarcoidosis, the most likely diagnosis is idiopathic adulthood ductopenia.
CONCLUSIONS: Based on these definitions, an algorithm for diagnosis and therapy in patients with laboratory evidence of chronic cholestasis may be constructed, pending results of further investigations into the etiopathogenesis of these syndromes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10811317     DOI: 10.1111/j.1572-0241.2000.01999.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  28 in total

1.  Identification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.

Authors:  Chao-Jun Hu; Guang Song; Wei Huang; Guo-Zhen Liu; Chui-Wen Deng; Hai-Pan Zeng; Li Wang; Feng-Chun Zhang; Xuan Zhang; Jun Seop Jeong; Seth Blackshaw; Li-Zhi Jiang; Heng Zhu; Lin Wu; Yong-Zhe Li
Journal:  Mol Cell Proteomics       Date:  2012-05-30       Impact factor: 5.911

Review 2.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

3.  Natural history of small duct primary sclerosing cholangitis: a case series with review of the literature.

Authors:  A K Singal; C M Stanca; V Clark; L Dixon; C Levy; J A Odin; M I Fiel; S L Friedman; N Bach
Journal:  Hepatol Int       Date:  2011-03-11       Impact factor: 6.047

4.  Small-duct primary sclerosing cholangitis. A single-center seven-year experience.

Authors:  Nikolaos L Nikolaidis; Olga I Giouleme; Konstantinos A Tziomalos; Kalliopi Patsiaoura; Eirini Kazantzidou; Anastasios D Voutsas; Themistoklis Vassiliadis; Nikolaos P Eugenidis
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

5.  Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.

Authors:  Benjamin L Woolbright; Daniel J Antoine; Rosalind E Jenkins; Mary Lynn Bajt; B Kevin Park; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2013-10-03       Impact factor: 4.219

6.  TNFalpha is required for cholestasis-induced liver fibrosis in the mouse.

Authors:  Erwin Gäbele; Matthias Froh; Gavin E Arteel; Takehiko Uesugi; Claus Hellerbrand; Jürgen Schölmerich; David A Brenner; Ronald G Thurman; Richard A Rippe
Journal:  Biochem Biophys Res Commun       Date:  2008-11-06       Impact factor: 3.575

Review 7.  Novel insight into mechanisms of cholestatic liver injury.

Authors:  Benjamin L Woolbright; Hartmut Jaeschke
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

Review 8.  Diagnosis and management of the overlap syndromes of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Can J Gastroenterol       Date:  2013-07       Impact factor: 3.522

9.  Protective effect of Jasonia montana against ethinylestradiol-induced cholestasis in rats.

Authors:  Mohammed A Hussein; Soad M Abdel-Gawad
Journal:  Saudi Pharm J       Date:  2009-12-23       Impact factor: 4.330

10.  A case of idiopathic adulthood ductopenia.

Authors:  Byeong Chool Park; Seon Mee Park; Eun Young Choi; Hee Bok Chae; Se Jin Yoon; Rohyun Sung; Sung Koo Lee
Journal:  Korean J Intern Med       Date:  2009-08-26       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.